P. Carpentier Et Al. , "Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial," INTERNATIONAL ANGIOLOGY , vol.36, no.5, pp.402-409, 2017
Carpentier, P. Et Al. 2017. Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial. INTERNATIONAL ANGIOLOGY , vol.36, no.5 , 402-409.
Carpentier, P., van Bellen, B., Karetova, D., Hanafiah, H., Enriquez-Vega, E., Kirienko, A., ... Dzupina, A.(2017). Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial. INTERNATIONAL ANGIOLOGY , vol.36, no.5, 402-409.
Carpentier, Patrick Et Al. "Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial," INTERNATIONAL ANGIOLOGY , vol.36, no.5, 402-409, 2017
Carpentier, Patrick Et Al. "Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial." INTERNATIONAL ANGIOLOGY , vol.36, no.5, pp.402-409, 2017
Carpentier, P. Et Al. (2017) . "Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial." INTERNATIONAL ANGIOLOGY , vol.36, no.5, pp.402-409.
@article{article, author={Patrick Carpentier Et Al. }, title={Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial}, journal={INTERNATIONAL ANGIOLOGY}, year=2017, pages={402-409} }